ATE553755T1 - Stärke enthaltende beschichtungszusammensetzung - Google Patents

Stärke enthaltende beschichtungszusammensetzung

Info

Publication number
ATE553755T1
ATE553755T1 AT07789340T AT07789340T ATE553755T1 AT E553755 T1 ATE553755 T1 AT E553755T1 AT 07789340 T AT07789340 T AT 07789340T AT 07789340 T AT07789340 T AT 07789340T AT E553755 T1 ATE553755 T1 AT E553755T1
Authority
AT
Austria
Prior art keywords
coating composition
containing coating
starch containing
starch
formulations
Prior art date
Application number
AT07789340T
Other languages
English (en)
Inventor
Gisela Fridrun Podczeck
Ana Cristina Teixeira De Almeida Freire
Original Assignee
Univ Sunderland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0614933A external-priority patent/GB0614933D0/en
Priority claimed from GB0617215A external-priority patent/GB0617215D0/en
Application filed by Univ Sunderland filed Critical Univ Sunderland
Application granted granted Critical
Publication of ATE553755T1 publication Critical patent/ATE553755T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Biological Depolymerization Polymers (AREA)
AT07789340T 2006-07-27 2007-07-20 Stärke enthaltende beschichtungszusammensetzung ATE553755T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0614933A GB0614933D0 (en) 2006-07-27 2006-07-27 Composition
GB0617215A GB0617215D0 (en) 2006-09-01 2006-09-01 Composition
PCT/GB2007/050428 WO2008012573A1 (en) 2006-07-27 2007-07-20 Coating composition comprising starch

Publications (1)

Publication Number Publication Date
ATE553755T1 true ATE553755T1 (de) 2012-05-15

Family

ID=38698207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07789340T ATE553755T1 (de) 2006-07-27 2007-07-20 Stärke enthaltende beschichtungszusammensetzung

Country Status (10)

Country Link
US (1) US20090285863A1 (de)
EP (1) EP2046306B8 (de)
JP (1) JP2009544684A (de)
AT (1) ATE553755T1 (de)
AU (1) AU2007279036A1 (de)
BR (1) BRPI0715362A2 (de)
CA (1) CA2658915A1 (de)
MX (1) MX2009001085A (de)
RU (1) RU2440104C2 (de)
WO (1) WO2008012573A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009105409A2 (en) * 2008-02-19 2009-08-27 Mc Neil-Ppc, Inc. Dip coated compositions containing a starch having a high amylose content
EP2179727B1 (de) 2008-10-27 2013-05-29 Roquette Freres Folienbeschichtungen aus wasserunlöslichem Polymer und modifiziertem Stärkederivat zur Dickdarmansteuerung
GB2567493B (en) * 2017-10-13 2019-12-18 Altus Formulation Inc Starch-based release modifying excipients and pharmaceutical compositions derived therefrom
GB201905940D0 (en) * 2019-04-29 2019-06-12 Intract Pharma Ltd 5-aminolevulinic acid for the local treatment of inflammatory bowel disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3034592B2 (ja) * 1990-11-20 2000-04-17 わかもと製薬株式会社 経口用固形製剤及びその製造法
GB9722426D0 (en) * 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
US6514526B1 (en) * 1998-03-27 2003-02-04 Valtion Teknillinen Tutkimuskeskus Coated starch capsules and a process for producing them
FR2785539B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
EP1137011B1 (de) * 2000-03-21 2008-12-10 STMicroelectronics S.r.l. Strang-programmierbarer nichtflüchtiger Speicher mit NOR-Architektur
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
JP5649784B2 (ja) * 2006-02-07 2015-01-07 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 組成物、基材を組成物でコーティングする方法、被覆基材、製品、フィルム、ペレット、タブレット及びカプセル

Also Published As

Publication number Publication date
EP2046306B1 (de) 2012-04-18
WO2008012573A1 (en) 2008-01-31
RU2009106260A (ru) 2010-09-10
CA2658915A1 (en) 2008-01-31
MX2009001085A (es) 2009-03-23
RU2440104C2 (ru) 2012-01-20
BRPI0715362A2 (pt) 2013-06-18
JP2009544684A (ja) 2009-12-17
EP2046306B8 (de) 2012-06-27
US20090285863A1 (en) 2009-11-19
EP2046306A1 (de) 2009-04-15
AU2007279036A1 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
CL2007002640A1 (es) Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2007002642A1 (es) Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer.
IL227934A (en) An immunogenic preparation containing polysaccharide or oligosaccharide from s. type 5 or 8 aureus and various aspects related to it
WO2007127333A3 (en) Compositions for the treatment and prevention of eyelid swelling
NO20082538L (no) Stabiliserte lantankarbonatsammensetninger
BRPI0718927A2 (pt) Método de imunização contra os quatro sorotipos da dengue.
TR200801337T1 (tr) Suda zayıf çözülebilen farmasötik ajanlar ve antimikrobiyal ajanlar içeren kompozisyonlar.
NO20091183L (no) Derivater av 4-(N-azacykloalkyl)-anilider, fremgangsmåte for fremstilling av slike forbindelser, preparater omfattende slike forbindelser samt anvendelse av slike forbindelser for forhindring eller behandling av sykdom
ECSP099634A (es) Derivados de piridazinona útiles como inhibidores de glucano sintasa
EP2476461A3 (de) Formulierungen zur Krebsbehandlung
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
WO2007103719A3 (en) MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
NI200700064A (es) Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3- trifluorometil-fenil)- ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos.
WO2008083157A3 (en) Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
JP2009516717A5 (de)
WO2007095258A3 (en) Rhamnolipid compositions and related methods of use
WO2007056073A3 (en) Medical device with a coating comprising an active form and an inactive form of therapeutic agent(s)
PT2056805E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de reacção tecidular
EP2300599A4 (de) Steigerung der wirksamkeit einer zelltherapie, einschliesslich behandlung mit alpha-1-3-fucosyltransferase
WO2009108932A3 (en) Selectin ligands useful in the diagnosis and treatment of cancer
WO2010078036A3 (en) Biocompatible polysaccharide-based hydrogels
EP2046306B8 (de) Stärke enthaltende beschichtungszusammensetzung
WO2006128041A3 (en) Compositions and methods for the treatment or prevention of chemoresistant neoplasia
WO2006097617A3 (fr) Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux
JP2009292763A5 (de)